2024 annual financial data
Autolus Therapeutics 2024 Revenue growth
Direct answer
Revenue growth was 496%.
Operating income was -241,426,000 USD and net income was -220,662,000 USD.
Operating cash flow was -206,271,000 USD.
Get free Autolus Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,120,000 USD
- Operating income
- -241,426,000 USD
- Net income
- -220,662,000 USD
- Operating cash flow
- -206,271,000 USD